未登录
分享
收藏Patient-reported outcomes with adjuvant nivolumab versus placebo after complete resection of stage IIB/C melanoma in the randomized phase 3 CheckMate 76 K trial在随机III期CheckMate 76 K试验中,接受完全切除的IIB/C期黑色素瘤患者使用辅助纳武利尤单抗 versus 安慰剂治疗后的患者报告结局。
Kirkwood, John M.; Mohr, Peter; Hoeller, Christoph; Grob, Jean-Jacques; Del Vecchio, Michele; Lord-Bessen, Jennifer; Srinivasan, Swetha; Nassar, Ayman; Campigotto, Federico; Fairbanks, Hannah; Taylor, Fiona; Lawrance, Rachael; Long, Georgina, V; Weber, Jeffrey
分享
收藏
分享
收藏
分享
收藏
分享
收藏
分享
收藏